Twenty-two insightful venture capital sessions reviewing the Asia growth story dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
Hi-tech lab taps advanced technology to boost Singapore s future pandemic response
Nanyang Technological University, Singapore (NTU Singapore) and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore s COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory.
Amid the ongoing global COVID-19 situation, the lab plans to tap advanced technology like Artificial Intelligence (AI) and data analytics to innovate, boosting the country s future pandemic response.
Situated at NTU Singapore s Lee Kong Chian School of Medicine (LKCMedicine) Novena Campus, the NTU Clinical Diagnostic Laboratory was set up in April 2020 by a team of academic researchers, in support of the national effort to increase diagnostic testing capacity and commenced Covid-19 polymerase chain reaction (PCR) testing on 1 July 2020.
Date Time
Preparing for future pandemics with hi-tech lab
NTU Singapore and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore’s COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory.
Amid the ongoing global COVID-19 situation, the lab plans to tap advanced technology like Artificial Intelligence (AI) and data analytics to innovate, boosting the country’s future pandemic response.
Situated at NTU Singapore’s Lee Kong Chian School of Medicine (LKCMedicine) Novena Campus, the NTU Clinical Diagnostic Laboratory was set up in April 2020 by a team of academic researchers, in support of the national effort to increase diagnostic testing capacity and commenced Covid-19 polymerase chain reaction (PCR) testing on 1 July 2020.
Hi-tech lab to boost COVID-19 diagnostic capability, prepare for future pandemics eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
SINGAPORE - The TracieX breathalyser by Singapore medtech firm Silver Factory Technology, which is currently being trialled, uses a sensor chip to identify the molecular fingerprint of volatile organic compounds present in the exhaled breath of Covid-19 patients.
A disposable breath collection chamber with infection control features securely traps any contagious material within the chamber, thus preventing direct exposure of these materials to others, such as healthcare workers.
Current studies
Unblinded studies - where participants have prior knowledge of their Covid-19 status - are ongoing at Changi Airport s Terminal 1 and the National Centre for Infectious Diseases (NCID).
Participants who volunteer to be part of the study will take two tests: the breathalyser and polymerase chain reaction (PCR) tests.